The FDA is encouraging new complex trial designs that are adaptive and/or Bayesian. This page describes a program where drug companies are encouraged to propose these designs and they publicly disclose the details so that others can learn from their successes (and failures).
U.S. Food and Drug Administration. Complex Innovative Trial Designs Pilot Program. Available in html format.